Multimodal Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma -ECF vs. FLOT

被引：0
|
作者：
Schroeder, W. [1 ]
Bruns, C. J. [1 ]
机构：
[1] Univ Klin Koln, Klin Allgemein Viszeral & Tumorchirurg, Kerpener Str 62, D-50937 Cologne, Germany
来源：
CHIRURG | 2019年 / 90卷
关键词：
D O I：
10.1007/s00104-019-0841-4
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy
    Min, L. Z.
    Liu, N.
    Zhou, Y.
    Niu, Z.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1106 - S1106
  • [22] Merendino Resection vs. Transhiatal Gastric Conduit After Resection of the Cardia and the Gastroesophageal Junction
    Eichelmann, Ann-Kathrin
    Nikitina, Milana
    Bahde, Ralf
    Mardin, Wolf A.
    Slepecka, Patrycja
    Kebschull, Linus
    Senninger, Norbert
    Pascher, Andreas
    Palmes, Daniel
    AMERICAN SURGEON, 2022, 88 (02) : 194 - 200
  • [23] Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT
    Sadia Tasnim
    Monisha Sudarshan
    Annals of Surgical Oncology, 2024, 31 : 21 - 22
  • [24] ANALYSIS OF SURGICAL INCURABILITY IN GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
    Zhao, H.
    Chen, W.
    Lin, Y.
    Qin, J.
    Wang, L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : E7 - E7
  • [25] Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
    Joshi, Smita S.
    Maron, Steven B.
    Catenacci, Daniel V.
    FUTURE ONCOLOGY, 2018, 14 (05) : 417 - 430
  • [26] Customizing Therapy for Esophageal Cancer: CROSS vs. FLOT
    Tasnim, Sadia
    Sudarshan, Monisha
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 21 - 22
  • [27] NEJM at ESMO - Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
    Rubin, Eric J.
    Yeku, Oladapo O.
    Morrissey, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (12):
  • [28] Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
    Schulz, Christoph
    Stintzing, Sebastian
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2175 - 2177
  • [29] Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions
    Richards, Donald A.
    Boehm, Kristi A.
    Anthony, Stephen P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) : 1059 - 1068
  • [30] Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis
    Walden, Daniel
    Sonbol, Mohamad Bassam
    Petty, Skye Buckner
    Yoon, Harry H.
    Borad, Mitesh
    Bekaii-Saab, Tanios S.
    Ahn, Daniel H.
    FRONTIERS IN ONCOLOGY, 2021, 11
12345